Naveen Padmanabhan1, Annapurneswari Subramanyan2, Selvi Radhakrishna3. 1. Registrar, Department of Surgical Oncology, Apollo Speciality Hospitals , Chennai-35, India . 2. Chief of Surgical Pathology, Department of Surgical Pathology, Apollo Speciality Hospitals , Chennai-35, India . 3. Senior Consultant, Department of Breast surgery and Oncoplastic Breast surgeon, Apollo Speciality Hospitals , Chennai-35, India .
Abstract
BACKGROUND: Bilateral breast cancer (BBC) is not an uncommon entity in contemporary breast clinics. Improved life expectancy after breast cancer treatment and routine use of contra-lateral breast mammography has led to increased incidence of BBC. Our study objective was to define the epidemiological and tumour characteristics of BBC in India. MATERIALS AND METHODS: A total of 1251 breast cancer patients were treated during the period January 2007 to March 2015 and 30 patients were found to have BBC who constituted the study population (60 tumour samples). Synchronous bilateral breast cancers (SBC) was defined as two tumours diagnosed within an interval of 6 months and a second cancer diagnosed after 6 months was labelled as metachronous breast cancer (MBC). Analyses of patient and tumour characteristics were done in this prospective data base of BBC patients. RESULTS: Median patient age was 66 years (range 39-85). Majority of the patients had SBC (n=28) and in 12 patients the second tumour was clinically occult and detected only by mammography of the contra-lateral breast. The second tumour was found at lower tumour size compared to the first in 73% of cases and was negative for axillary metastasis in 80% of cases (24/30). Infiltrating ductal carcinoma was the commonest histological type (n=51) and majority of the tumours were ER/PR positive (50/60). Her2 was overexpressed in 13 tumours (21%). Over 70% (22/30) of patients had similar histology in both breasts and amongst them grade concordance was present in about 69% (15/22) of patients. Concordance rates of ER, PR and Her2 statuses were 83%, 80% and 90% respectively. Bilateral mastectomy was the commonest surgery performed in 80% of the patients followed by bilateral breast conservation in 13%. At the end of study period, 26 patients were alive and disease free. Median survival was 29 months (range 3-86 months). CONCLUSION: In most patients with BBC, the second tumour is identified at an early stage than index tumours supporting the importance of contralateral breast cancer screening at the time of primary diagnosis and during follow-up. BBC occurs more frequently in old age group and majority of these tumours are estrogen dependent. There is good pathological concordance between the index tumour and the contralateral breast cancer.
BACKGROUND:Bilateral breast cancer (BBC) is not an uncommon entity in contemporary breast clinics. Improved life expectancy after breast cancer treatment and routine use of contra-lateral breast mammography has led to increased incidence of BBC. Our study objective was to define the epidemiological and tumour characteristics of BBC in India. MATERIALS AND METHODS: A total of 1251 breast cancerpatients were treated during the period January 2007 to March 2015 and 30 patients were found to have BBC who constituted the study population (60 tumour samples). Synchronous bilateral breast cancers (SBC) was defined as two tumours diagnosed within an interval of 6 months and a second cancer diagnosed after 6 months was labelled as metachronous breast cancer (MBC). Analyses of patient and tumour characteristics were done in this prospective data base of BBC patients. RESULTS: Median patient age was 66 years (range 39-85). Majority of the patients had SBC (n=28) and in 12 patients the second tumour was clinically occult and detected only by mammography of the contra-lateral breast. The second tumour was found at lower tumour size compared to the first in 73% of cases and was negative for axillary metastasis in 80% of cases (24/30). Infiltrating ductal carcinoma was the commonest histological type (n=51) and majority of the tumours were ER/PR positive (50/60). Her2 was overexpressed in 13 tumours (21%). Over 70% (22/30) of patients had similar histology in both breasts and amongst them grade concordance was present in about 69% (15/22) of patients. Concordance rates of ER, PR and Her2 statuses were 83%, 80% and 90% respectively. Bilateral mastectomy was the commonest surgery performed in 80% of the patients followed by bilateral breast conservation in 13%. At the end of study period, 26 patients were alive and disease free. Median survival was 29 months (range 3-86 months). CONCLUSION: In most patients with BBC, the second tumour is identified at an early stage than index tumours supporting the importance of contralateral breast cancer screening at the time of primary diagnosis and during follow-up. BBC occurs more frequently in old age group and majority of these tumours are estrogen dependent. There is good pathological concordance between the index tumour and the contralateral breast cancer.
Entities:
Keywords:
Breast neoplasms; Estrogen receptor; Histology; Mammography
Authors: K M Heaton; G E Peoples; S E Singletary; B W Feig; M I Ross; F C Ames; T A Buchholz; E A Strom; M D McNeese; K K Hunt Journal: Ann Surg Oncol Date: 1999 Jan-Feb Impact factor: 5.344
Authors: Alan M Nichol; Rinat Yerushalmi; Scott Tyldesley; Mary Lesperance; Chris D Bajdik; Caroline Speers; Karen A Gelmon; Ivo A Olivotto Journal: J Clin Oncol Date: 2011-11-21 Impact factor: 44.544
Authors: Helena M Verkooijen; Vanessa Chatelain; Gérald Fioretta; Georges Vlastos; Elisabetta Rapiti; André-Pascal Sappino; Christine Bouchardy; Pierre O Chappuis Journal: Breast Cancer Res Treat Date: 2006-12-21 Impact factor: 4.872
Authors: L A Newman; A A Sahin; J E Cunningham; M L Bondy; N Q Mirza; G S Vlastos; G J Whitman; H Brown; T A Buchholz; M H Lee; S E Singletary Journal: Cancer Date: 2001-05-15 Impact factor: 6.860
Authors: Evgeny N Imyanitov; Evgeny N Suspitsin; Maxim Yu Grigoriev; Alexandr V Togo; Ekatherina Sh Kuligina; Evgeniya V Belogubova; Kazymir M Pozharisski; Elena A Turkevich; Carmen Rodriquez; Cees J Cornelisse; Kaido P Hanson; Charles Theillet Journal: Int J Cancer Date: 2002-08-10 Impact factor: 7.396
Authors: Diane M Renz; Joachim Böttcher; Pascal A T Baltzer; Matthias Dietzel; Tibor Vag; Mieczyslaw Gajda; Oumar Camara; Ingo B Runnebaum; Werner A Kaiser Journal: Breast Cancer Res Treat Date: 2010-01-20 Impact factor: 4.872
Authors: David Roder; Primali de Silva; Helen Zorbas; James Kollias; Peter Malycha; Chris Pyke; Ian Campbell; Fleur Webster Journal: Asian Pac J Cancer Prev Date: 2012
Authors: M Valli; S Cima; D Gaudino; R Cartolari; L Deantonio; M Frapolli; D Daniele; G A Pesce; F Martucci; N C Azinwi; D Bosetti; S Presilla; A Richetti Journal: Clin Transl Oncol Date: 2019-03-14 Impact factor: 3.405